Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000897069-18-000496
Filing Date
2018-08-07
Accepted
2018-08-07 11:08:09
Documents
1
Effectiveness Date
2018-08-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9383
  Complete submission text file 0000897069-18-000496.txt   10446
Mailing Address 12085 RESEARCH DRIVE SUITE 46 ALACHUA FL 32615
Business Address 12085 RESEARCH DRIVE SUITE 46 ALACHUA FL 32615 (352) 514-7669
Lacerta Therapeutics, Inc. (Filer) CIK: 0001748465 (see all company filings)

EIN.: 474668812 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-318608 | Film No.: 18996717